NS 14606Alternative Names: NS14606
Latest Information Update: 10 Mar 2017
At a glance
- Originator NeuroSearch
- Class Anxiolytics
- Mechanism of Action GABA A receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued CNS disorders
Most Recent Events
- 09 Mar 2017 Discontinued - Preclinical for CNS disorders in Denmark (unspecified route) before March 2017 (NeuroSearch email communication, March 2017)